Abiopharma

New Form 8-K - Lyra Therapeutics, Inc. Filed: 2025-06-27 AccNo: 0001193125-25-150301 Size: 685 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits